Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-10-20
1991-06-25
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514370, 546209, 548181, C07D41704, A61K 31425
Patent
active
050267159
ABSTRACT:
2-Guanidino-4-arylthiazole compounds of the formula ##STR1## a pharmaceutically acceptable cationic or acid addition salt thereof wherein
REFERENCES:
patent: 3591584 (1971-07-01), Lombardino
patent: 3758491 (1973-09-01), Capps
patent: 4293549 (1981-10-01), Rachlin et al.
patent: 4374843 (1983-02-01), LaMattina et al.
patent: 4435396 (1984-03-01), LaMattina et al.
patent: 4560690 (1985-12-01), Reiter
patent: 4791200 (1988-12-01), Press
Medicinal Chemistry, Third Edition, Alfred Burger, Ed., Wiley-Interscience, pp. 75-77.
Rachlin, S. et al., "Basic Antiinflammatory Compounds, N,N',N"-Trisubstituted Guanidines", J. Med. Chem. 23, 13-20 (1980).
Lombardino, J. et al., "Potent Antiinflammatory N-Heterocyclic 3-Carboxamides of 4-Hydroxy-2-Methyl-2H-1,2-Benzothiazine 1,1-Dioxide", J. Med. Chem. 16, 493-496 (1973).
LaMattina John L.
McCarthy Peter A.
Reiter Lawrence A.
Benson Gregg C.
Gerstl Robert
Lumb J. Trevor
Pfizer Inc.
Richardson Peter C.
LandOfFree
2-guanidino-4-arylthiazoles for treatment of peptic ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-guanidino-4-arylthiazoles for treatment of peptic ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-guanidino-4-arylthiazoles for treatment of peptic ulcers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040114